Coming Soon

Tecrea specializes in providing innovative technology solutions and consulting services to optimize business processes, enhance operational efficiency, and drive digital transformation across various industries.
Spinout Company
Public Funding Received
2025-09-01
Exploring the Feasibility of Lidocaine:Nanocin™ Antimicrobial Formulation in Treating Recurrent Urinary Tract Infections
Feasibility Studies
2024-07-01
Novel AMD Treatment via Topical Nanocin Delivery of Anti-VEGF
Collaborative R&D
2024-07-01
NANOZYME - Endo-metritis therapy for dairy cows – combining tissue release and infection control
Collaborative R&D
2021-05-01
Scalable AAV production in high density suspension HEK293SF-3F6 cell culture using Nanocin transfection
Collaborative R&D
2020-08-01
Development of a coupled inactivating transport medium and RNA purification protocol for SARS-CoV-2
Collaborative R&D
2018-05-01
Improving ophthalmic drug delivery by novel formulations: peptidic hydrogels and nanoparticles
Feasibility Studies
2017-06-01
Track and measure polymeric nanoparticles
Collaborative R&D
2015-05-01
Scalable AAV Production using Novel Hollow Fibre Bioreactors
Feasibility Studies
2014-08-01
Modulating intracellular oncology targets using Adhirons™ – a novel therapeutic approach
Feasibility Studies
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2013-08-01
Formulation of messenger RNA for Intracellular Delivery and Expression
Feasibility Studies
2013-08-01
Formulation and stability of biological products for skin delivery focussing on Retinol.
Feasibility Studies
2012-11-01
IP protection of Nanocin for Infectious Disease Therapy
Vouchers
2012-08-01
Non-toxic Platform for Biomolecule Delivery into Cells
Feasibility Studies